Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (CRON)
NASDAQ:CRON
Holding CRON?
Track your performance easily
CRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.86 - $3.14
Previous Close$2.01
Volume3.03M
Average Volume (3M)1.12M
Market Cap
$760.36M
Enterprise Value-$50.07M
Total Cash (Recent Filing)$862.03M
Total Debt (Recent Filing)$1.85M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Mar 04, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding382,280,725
10 Day Avg. Volume1,197,006
30 Day Avg. Volume1,115,538
Standard Deviation0.15
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.71
Price to Sales (P/S)7.09
Price to Cash Flow (P/CF)16.40
P/FCF Ratio35.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.45
Enterprise Value/Gross Profit-4.20
Enterprise Value/Ebitda1.10
Forecast
1Y Price Target
$2.00Price Target Upside-0.50% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
Cronos Group News
PremiumCompany Announcements
Cronos Group Sees Revenue Surge and Market Dominance
Bulls Say, Bears Say
Bulls Say
Cost ManagementOperating expenses decreased by 8% year-over-year, driven by effective sales and cost controls, enhancing overall financial efficiency.
Financial PerformanceCRON's 2Q24 net sales were $27.8 million, a 46% increase year-over-year and a quarterly high, reflecting strong financial performance.
Sales GrowthCronos Group is showing progress in sales growth and cost reduction, which indicates some improvement in the company's financial health.
Bears Say
Profitability UncertaintyThe timing of profitability, disruptions due to the Israel-Hamas war, changes to US federal laws and Canadian reform to the Cannabis Act are unclear.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation ConcernsCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.
---
Ownership Overview
3.41% Insiders
1.76% Mutual Funds
― Other Institutional Investors
90.46% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $1.86 and its highest was $3.14 in the past 12 months.
What is Cronos Group’s market cap?
Currently, no data Available
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Mar 04, 2025 which is in 70 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Nov 12, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.005 by $0.015.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Overvalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is $0.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,294,700 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of $0.02 in its last earnings report, beating expectations of $0.005. Following the earnings report the stock price went up 14.721%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
---
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Cronos demonstrated significant revenue growth and market leadership in Canada and international markets, with strong financial performance. However, challenges such as flower supply shortages and geopolitical issues in Israel were noted. The overall sentiment of the call is positive, given the significant achievements outweighing the challenges.Read More>---
CRON Stock 12 Month Forecast
Average Price Target
$2.00
▼(-0.50% Downside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
12/21 ratings generated profit
1 Year Average Return
+10.57%
reiterated a buy rating 5 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +10.57% per trade.
---